SEC 13F Intelligence

Geneva Partners, LLC / AZNN

Geneva Partners, LLC’s Astrazeneca PLC Position

Does Geneva Partners, LLC own Astrazeneca PLC (AZNN)? Not currently — the last reported position was 26.7K shares worth $2M in Q2 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q2 2023
Shares
26.7K
% of Portfolio
+1.25%
Quarters Held
5
position exited

Position History AZNN

Reported value by quarter
Q2 ’22: $3MQ2 ’22Q3 ’22: $1MQ3 ’22Q4 ’22: $1MQ4 ’22Q1 ’23: $1MQ1 ’23Q2 ’23: $2MQ2 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202326.7K$2M+1.25%
Q1 202316.7K$1M+0.99%
Q4 202216.9K$1M+1.08%
Q3 202222.2K$1M+1.39%
Q2 202249.0K$3M+3.19%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Geneva Partners, LLC’s full portfolio or all institutional holders of AZNN.